Glipita-M is the preparation of sitagliptin and metformin. Sitagliptin phosphate, a dipeptidyl peptidase 4(DPP-4) inhibitor and metformin HCI, a member of the biguanide class. Glipita-M is indicated as an adjunct to diet and exercise to treat Type 2 diabetes where metfromin is not enough to improve glycemic control. FDA Approves Glipita-M For Type 2 Diabetes, Offering Powerful Glucose Control Of A DPP-4 Inhibitor And Metformin in a Single Tablet.
landline : +218-21-350-4495
Mobile : +218–91–6792805
16 st branch of 20 Ramadan road, Soug aljomaa
Tripoli – Libya
© 2021 ramsa.ly, All Rights Reserved